content

Print Issue December 2025

content — Fri, 12 Dec 2025 07:23:05 +0000

Print Issue September 2025

content — Fri, 12 Sep 2025 05:01:11 +0000

Print Issue April 2025

content — Wed, 09 Jul 2025 11:41:22 +0000

Gene Therapy for Hearing Loss: A Translational Development Roadmap

content — Thu, 15 May 2025 06:16:16 +0000

Hearing loss is a significant public health issue affecting over 466 million people globally. Hearing aids and cochlear implants fail to address the underlying causes. Gene therapy targets the fundamental genetic causes of hearing loss, providing true auditory regeneration and natural hearing restoration, offering hope for millions seeking effective solutions. Gene therapy has advanced rapidly […]

The post Gene Therapy for Hearing Loss: A Translational Development Roadmap first appeared on World Pharma Today.

Jason Shuris of Indero on the future of CROs & Rheumatology

content — Wed, 14 May 2025 13:36:12 +0000

Jason Shuris is the Chief Business Officer at Indero, formerly known as Innovaderm. Jason has more than 25 years of experience in the life sciences and CRO (contract research organization) sectors. His vast experience in clinical research and strategic operations has placed him at the forefront of Indero’s evolution, especially during the company’s recent rebranding […]

The post Jason Shuris of Indero on the future of CROs & Rheumatology first appeared on World Pharma Today.

Executive Interview Series with datma CEO Noah Nasser

content — Fri, 09 May 2025 13:42:38 +0000

datma is a leading provider of federated Real-World Data platforms and related tools for data analysis and visualization. datma’s mission is to empower healthcare organizations, including providers, clinicians, and researchers, to optimize their data assets, driving innovation and improving patient lives globally. Based in Oregon, the company, through its two-sided marketplace datma.FED is at the […]

The post Executive Interview Series with datma CEO Noah Nasser first appeared on World Pharma Today.

Quality Creates Value: Unlocking Quality Culture as a Competitive Edge in the Pharmaceutical Industry

content — Mon, 05 May 2025 05:20:06 +0000

Pharmaceutical companies play a critical role in global health. While much of their time is spent on innovation, their ability to deliver essential medicines with quality, consistency, dependability, affordability, and in sufficient volumes is essential to the wellbeing of every community. Given the complexity of pharmaceutical manufacturing and the high stakes involved, the importance of […]

The post Quality Creates Value: Unlocking Quality Culture as a Competitive Edge in the Pharmaceutical Industry first appeared on World Pharma Today.

Ethical AI Investment: The Key to Sustainable Healthcare Innovation in Europe

content — Tue, 29 Apr 2025 11:00:38 +0000

In this exclusive interview, World Pharma Today sits down with Laurent Van Lerberghe and David Buller, the Managing Partners of KELES, deeply engaged in ethical AI investments, particularly within the healthcare and pharmaceutical sectors. The conversation explores their insights into the role of ethical AI in business, challenges in transparency and accountability, compliance with evolving […]

The post Ethical AI Investment: The Key to Sustainable Healthcare Innovation in Europe first appeared on World Pharma Today.

Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research

content — Sat, 26 Apr 2025 06:39:41 +0000

Martigny, Switzerland. Dijon, France – Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer and infectious diseases, and Oncodesign Services (www.oncodesign-services.com), a leading CRO specialized in drug discovery and preclinical services, announce the execution of a license agreement for the use of the AbYlink™ technology for preclinical services. AbYlink™ […]

The post Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research first appeared on World Pharma Today.

Meribel Pharma Solutions launches with big ambitions to elevate pharma services to new heights

content — Tue, 22 Apr 2025 09:16:02 +0000

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched today with an extensive integrated network across Europe, led by a team of industry experts on a mission to deliver the highest quality solutions and services to enable customers to scale to new heights and improve patient health. The firm has ten manufacturing […]

The post Meribel Pharma Solutions launches with big ambitions to elevate pharma services to new heights first appeared on World Pharma Today.